Cancer Advances, Inc. announces new publication: “Gastrin Vaccine Improves Response to Immune Checkpoint Antibody in Murine Pancreatic Cancer by Altering the Tumor Microenvironment”, in the journal Cancer Immunology, Immunotherapy

Polyclonal Antibody Stimulator (PAS) monotherapy elicits both a humoral and a cellular immune response when used in immune competent mice bearing pancreatic tumors.